We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Futura Medical Plc | LSE:FUM | London | Ordinary Share | GB0033278473 | ORD 0.2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.20 | -0.56% | 35.20 | 35.30 | 35.75 | 35.45 | 35.20 | 35.45 | 109,930 | 11:34:49 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -5.85M | -0.0194 | -18.14 | 105.85M |
Date | Subject | Author | Discuss |
---|---|---|---|
23/6/2023 16:05 | LBOs diarrhoea is getting worse with the spike in volume today. Hope he doesn't dehydrate - it's a warm day. | wheeze | |
23/6/2023 15:55 | It is so sad that the 'discussion' here is limited to a couple of people who keep reposting the same thing.It is still the case that the share is up 25% since the UK launch.Who really knows how effective the gel has been for the millions of people who have bought it? | ajmace | |
23/6/2023 15:15 | fum value maths april 2024 rev 14m 4m loss 10m profit, > 2 90m shares = 3.44 eps share price 60p > p/e 17.44 a nice number. happy days BB | black bird | |
23/6/2023 13:21 | The people who are disappointed with Erexon are most likely those for nothing will work. Hence the bitterness. | joestalin | |
23/6/2023 13:18 | People are far more likely to post negative reviews than positive. After all what is the motivation to leave a review if it works ? If it doesn't work they feel cheated out of twenty five quid, hence they log on and leave a rubbish review.Let's face it if a million people use it and 250 leave bad reviews that is not necessarily a negative outcome.Everyone knows (except Lombo) that the vast majority of erectile dysfunction is functional. It is this group that will be helped. With regard to the others, you can heal the sick but you can't raise the dead. | wheeze | |
23/6/2023 11:58 | I also tried Eroxon twice. It did absolutely nothing. Hence I think this share looks a ramped up scam. | paulypilot | |
23/6/2023 11:55 | Don't listen to your critics, LBO, they no doubt find your well researched and factual posts somewhat of a threat. A bubble ready to pop? Maybe so. Virtually all the recent reviews on Boots are 1 star, totally slamming eroxon, and almost all are "verified purchases" which puts to bed the rampers' theory they're all made up. I'm fairly sure any potential US partner will include such reviews in their due diligence, and it's all pretty damning! | thebutler | |
23/6/2023 10:36 | Having witnessed LBOs diarrhoeal posts trying to infuse negativity into every aspect of owning this share, makes me wonder what his / her / its' motives are. No drug or pharmaceutical product has 100 percent efficacy. Does paracetamol cure every headache? The manufacturers makes no claim that Eroxxon will help everyone who suffers from ED. It is understood that many will not benefit nevertheless the product will help many who do.What could be LBOs hidden agenda ? Who would want to limit the rise in share price ?The Majority shareholder owns 25.99 percent of the company. Their thinking is clearly at odds with their eponymous poster LBO, who thinks FUM is worth nothing.Would the majority shareholder consider taking FUM off the market ? Hmm, there's a thought. Would they be interested in keeping the share price down ? Perhaps. Don't be misled by spam posters like LBO. They always have a hidden agenda which is definitely not your welfare.Do your own research. I have. | wheeze | |
23/6/2023 08:43 | They even seem to have ways of posting under other peoples names.I did not submit the one two hours ago which appears under my name! | ajmace | |
23/6/2023 08:34 | Real investors beware.This board is dominated by individuals who have their own agenda.Do not expect reasoned opinion. | ajmace | |
23/6/2023 06:57 | amaretto1 - sorry to hear it didn' work. But why should investors try the product if they don't have any ED issues. I will say maybe the company should publisce that it only works for 60-65% for the male population. Also investor should already know that it doesn't work for everyone. | keifer derrin | |
23/6/2023 06:41 | And this is not a sour grapes post ...My friend is heavily invested here I've told him exactly the same ... the results i got ....if your a investor here .. you should at least be trying it yourself !! | amaretto1 | |
23/6/2023 06:36 | Any one on here tried it ? i have ... it didn't work ...It cost 25 pounds from under the counter at Boots ... Wasn't impressed at all. | amaretto1 | |
22/6/2023 19:28 | LiarBOoth, 25th Sept 2017: '... neither of you are helping yourselves by carrying on in the current manner and taking over the bulletin board.' The hypocrisy and irony is overwhelming. | petroc | |
22/6/2023 12:29 | LBOWhy are you so keen to see it fail?Are you a better judge than those involved in the clinical trials? | ajmace |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions